HONG KONG – The CFDA is getting closer to completing a new revision of the country's Pharmaceutical Administration Law. After drastically increasing the registration fees for pharmaceuticals this year, the CFDA is now soliciting opinions on a draft guideline for the registration inspection of imported pharmaceutical products.